ArticleFrontiers in oncology2026
Clear cell renal cell carcinoma presenting as isolated symptomatic lumbar vertebral metastasis: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a rare case of clear cell renal cell carcinoma (ccRCC) initially presenting as an isolated symptomatic lumbar vertebral metastasis. A 62-year-old man presented with progressive low back pain radiating to the right lower extremity. Elevated prostate-specific antigen (PSA) levels initially raised strong suspicion for prostate cancer with bone metastasis. However, comprehensive multimodal imaging combined with histopathological evaluation ultimately established the diagnosis of right-sided ccRCC with metastasis to the fourth lumbar vertebra (L4). This case highlights the critical importance of a systematic and multimodal diagnostic approach for bone lesions of unknown primary origin, even in the presence of misleading tumor-specific indicators. We further discuss the diagnostic challenges associated with occult RCC, key differential diagnoses, the role of multidisciplinary team (MDT) management, and current combined therapeutic strategies for metastatic RCC. Clear cell renal cell carcinoma, Bone metastasis, Lumbar vertebra, Unknown primary tumor, Multimodal diagnosis, Multidisciplinary team.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.